Rebecca Dabora, PhD

Rebecca Dabora, PhD has extensive work experience in the biopharmaceutical industry. Currently, they serve as the Chief Technical Officer at Apogee Therapeutics. Prior to this role, they were the President and Principal of RDBio Consulting LLC, where they provided consulting services to various biopharmaceutical companies and venture capital firms. Their expertise in Technical Operations and CMC-related topics, including contract manufacturing assessment, process validation, and CMC regulatory filing preparation, contributed to the development and commercialization of multiple biologics and small molecule products.

Rebecca also held positions as the Chief Technology and Manufacturing Officer at Invivyd, Inc and Adagio Therapeutics, and served as the Interim CTO at SwanBio Therapeutics. Additionally, they worked as the Chief Technology Officer at Aspyrian Therapeutics, Inc and held the role of Vice President, Technical Operations at Altus Pharmaceuticals.

Before transitioning into consulting and industry roles, Rebecca gained significant experience at Biogen, where they held positions of increasing responsibility in the Process Development department. Rebecca was responsible for process development for clinical and commercial programs and served as a Program Executive for one of Biogen's clinical programs. Prior to Biogen, they worked as a Senior Scientist at Merck.

Rebecca's work experience demonstrates their expertise in technical operations, CMC regulatory affairs, process development, program management, and strategic and organizational development within the biopharmaceutical industry.

Rebecca Dabora, PhD, has a B.A. in Biochemistry from Bowdoin College. Rebecca also holds a Ph.D. in Applied Biological Sciences/Biochemical Engineering from Massachusetts Institute of Technology.